Atea Pharmaceuticals Inc.

03/28/2022 | Press release | Distributed by Public on 03/29/2022 13:14

4794: Characterization of the Toxicity Profile of AT-527 (Bemnifosbuvir), a Novel Guanosine Nucleotide Prodrug with Antiviral Activity for COVID-19 Infection